+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cancer Diagnostics Market, By Test, Technology, Application, End User, & By Region - Forecast and Analysis 2022-2027

  • PDF Icon

    Report

  • 157 Pages
  • January 2022
  • Region: Global
  • SkyQuest Technology Consulting
  • ID: 5583827
The global cancer diagnostics market was valued at USD 128.30 Billion in 2021, and it is expected to reach a value of USD 203.60 Billion by 2027, at a CAGR of more than 8.00% over the forecast period (2022 - 2027). This growth is mainly attributed to the growing prevalence of cancer across the globe, rising awareness of early diagnosis, increased funding for cancer R&D, technological advancements in diagnostic tests, and growth in the number of private diagnostics centers. This growth is also aided by a variety of private-sector projects. However, due to high costs, low reimbursement rates, and budgetary constraints, many hospitals in developing countries are unable to invest in diagnostic imaging technology. Because of the strong demand for diagnostic imaging treatments in these countries, hospitals that can't afford to invest in new imaging systems prefer to use refurbished ones. Refurbished systems are less expensive than new systems, with prices ranging from 40% to 60% of the original cost of the equipment.



The report provides market sizing and forecast across five major regions, namely, North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), and Middle East & Africa (MEA). In this report, the year 2016 to 2020 is considered a historical year, 2021 is the base year, 2022 is the estimated year, and years from 2022 to 2027 are considered the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global cancer diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Aspects covered in this report

  • Based on Test type, this market is segmented into instrument-based tests, laboratory tests, and liquid biopsies.
  • Based on technology, this market is categorized into platform-based and instrument-based.
  • Based on application, this market is segmented into Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach, Liver, Oesophagus, Thyroid, Pancreatic Cancer, Leukaemia, Other Malignancies.
  • Based on end-user, this market is segmented into hospitals, diagnostic laboratories other end users.
  • Based on region, this market is categorized into North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), and Middle East & Africa (MEA).

Players in this market adopted various strategies to expand their global footprint and augment their market share. The key strategies followed by most companies in the global cancer diagnostics market were agreements and collaborations, mergers and acquisitions, and expansion. The major players operating in this market include Becton, Dickinson and Company, GE Healthcare (A Subsidiary of General Electric Company), Abbott, Roche, QIAGEN N.V., Philips Healthcare, and Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., and Siemens Healthcare.
Frequently Asked Questions about the Global Cancer Diagnostics Market

What is the estimated value of the Global Cancer Diagnostics Market?

The Global Cancer Diagnostics Market was estimated to be valued at $128.3 Billion in 2021.

What is the growth rate of the Global Cancer Diagnostics Market?

The growth rate of the Global Cancer Diagnostics Market is 8.0%, with an estimated value of $203.6 Billion by 2027.

What is the forecasted size of the Global Cancer Diagnostics Market?

The Global Cancer Diagnostics Market is estimated to be worth $203.6 Billion by 2027.

Who are the key companies in the Global Cancer Diagnostics Market?

Key companies in the Global Cancer Diagnostics Market include Becton, Dickinson and Company, Ge Healthcare (A Subsidiary of General Electric Company), Abbott, Roche, Qiagen N.V., Philips Healthcare, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc. and Siemens Healthcare.

Table of Contents

Executive Summary
Market overview
  • Exhibit: Executive Summary - Chart on Market Overview
  • Exhibit: Executive Summary - Data Table on Market Overview
  • Exhibit: Executive Summary - Chart on Global Market Characteristics
  • Exhibit: Executive Summary - Chart on Market by Geography
  • Exhibit: Executive Summary - Chart on Market Segmentation
  • Exhibit: Executive Summary - Chart on Vendor Market Positioning

KEY MARKET INSIGHTS
  • Demand Side Trends
  • Supply Side Trends
  • Price Trend
  • Historic
  • (Exhibit: Data Analysis on Historic Price, 2016 - 2020, $)
  • Current
  • (Exhibit: Data Analysis on Current Price, 2021 ($))
  • Forecast
  • (Exhibit: Data Analysis on Forecast Price, 2022-2027 ($))
  • Technology Analysis
  • (Exhibit: Data Table: Name of technology and details)
  • Patent Analysis
  • (Exhibit: Data Table: Name of Patents and details)
  • Trade Analysis
  • Key Exporting and Importing Countries
  • (Exhibit: Data Table: Import Data, 2016 - 2021)
  • (Exhibit: Data Table: Export Data, 2016 - 2021)
  • Value Chain Analysis
  • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
  • Exhibit: Parent Market Ecosystem Market Analysis
  • Exhibit: Market Characteristics of Parent Market

COVID IMPACT
  • Introduction
  • Impact On Economy - scenario Assessment
  • Exhibit: Data on GDP - Year-over-year growth 2020-2027 (%)
  • Revised Market Size
  • Exhibit: Data Table on Global - Market size and forecast 2020-2027 ($ Billion)
  • Impact Of COVID On Key Segments
  • Exhibit: Data Table on Segment Market size and forecast 2020-2027 ($ Billion)
  • COVID Strategies by Company
  • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK
  • Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Exhibit: Data Table on regulation from different region
  • Porters Analysis
  • Competitive rivalry
  • Exhibit: Competitive rivalry Impact of key factors, 2021
  • Threat of substitute products
  • Exhibit: Threat of Substitute Products Impact of key factors, 2021
  • Bargaining power of buyers
  • Exhibit: buyers bargaining power Impact of key factors, 2021
  • Threat of new entrants
  • Exhibit: Threat of new entrants Impact of key factors, 2021
  • Bargaining power of suppliers
  • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Special insights on future disruptions
  • Technical Impact
  • Economic impact
  • Social Impact

Global Cancer Diagnostics Market by Test type
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Instrument-Based Tests
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Laboratory Tests
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Liquid Biopsies
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)

Global Cancer Diagnostics Market by Technology
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Platform-Based
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Instrument-Based
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)

Global Cancer Diagnostics Market by Application
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Lung Cancer
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)
  • Breast Cancer
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)
  • Colorectal Cancer
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)
  • Prostate Cancer
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)
  • Stomach
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)
  • Liver
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)
  • Oesophagus
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)
  • Thyroid
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)
  • Pancreatic Cancer
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)
  • Leukaemia
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)

Global Cancer Diagnostics Market by End-User
  • Market Segments
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Data Table on Market Share 2021-2027 (%)
  • Hospitals
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)
  • Diagnostic Laboratories
  • Market Estimates & Forecast, 2021-2027
  • Exhibit: Chart on Market Share 2021-2027 (%)
  • Exhibit: Market Size And Forecast 2021-2027 ($ Billion)

Market Size by Region
  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • USA
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Canada
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Europe
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Germany
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Spain
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • France
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • UK
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Rest of Europe
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Asia Pacific
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • China
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • India
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Japan
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • South Korea
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Rest of Asia Pacific
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Latin America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Brazil
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Rest of South America
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Middle East & Africa (MEA)
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • GCC Countries
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • South Africa
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)
  • Rest of MEA
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ Billion)

KEY COMPANY PROFILES
  • Competitive Landscape
  • Total number of companies covered
  • Exhibit: companies covered in the report, 2020
  • Top companies market positioning
  • Exhibit: company positioning matrix, 2020
  • Top companies market Share
  • Exhibit: Pie chart analysis on company market share, 2020(%)
  • BECTON
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • DICKINSON AND COMPANY
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • ABBOTT
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • ROCHE
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • QIAGEN N.V.
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • PHILIPS HEALTHCARE
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • THERMO FISHER SCIENTIFIC, INC.
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • AGILENT TECHNOLOGIES, INC.
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • ILLUMINA, INC.
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • SIEMENS HEALTHCARE
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Becton, Dickinson and Company
  • Ge Healthcare (A Subsidiary of General Electric Company)
  • Abbott
  • Roche
  • Qiagen N.V.
  • Philips Healthcare
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Siemens Healthcare